FDA lifts clinical hold on Gilead’s investigational HIV treatment May 17, 2022 Auto Bot Clinical Development 0 The agency has removed the hold placed on the pharmaceutical companyâs IND for injectable lenacapavir, which is intended for HIV treatment and prevention.
